News | Radiation Therapy | February 18, 2016

ASTRO Commends Proposed Cancer Research Increases in President’s 2017 Budget

Budget request includes $1 billion for Cancer Moonshot Initiative and 13 percent increase in biomedical research funding at the National Cancer Institute

ASTRO, Fiscal Year 2017 Budget, cancer research, Moonshot Initiative

February 18, 2016 — The American Society for Radiation Oncology (ASTRO) commended the proposed investment in cancer-related research announced in the Fiscal Year 2017 Budget released last week by the White House. ASTRO, whose members include nearly all practicing radiation oncologists in the United States, further encouraged policymakers to increase levels of sustained financial support for research on cancer treatment, detection and prevention as the Cancer Moonshot Initiative matures.

The President’s FY2017 budget includes requests for $5.9 billion to support biomedical research at the National Cancer Institute, an increase of $680 million (13 percent) from FY2016 levels, as well as $1 billion to accelerate progress in cancer treatment and detection through the Cancer Moonshot Initiative.

ASTRO sent a letter to Vice President Joe Biden articulating the multiple reasons it supports the moonshot effort, including a growing need to develop and employ radiation in combination with other therapies for cancer treatment; opportunities to leverage advances in “big data” analytics; and a need to increase access to clinical trials and the latest cancer research.

“Never before have clinicians been able to induce remission in those suffering from cancer like they have today through the use of radiation therapy in combination with other treatment modalities,” wrote ASTRO chair Bruce D. Minsky, M.D., FASTRO, in the letter. “Now is the time for siloed fields to coalesce and synergize to drive progress in leaps rather than in small increments. … To do this, the funding structure must reflect the reality that the most successful treatment will not be a single modality but rather a combination that includes radiation therapy, chemotherapy and surgery.”

For more information: www.astro.org

Related Content

Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Sponsored Content | Webinar | Artificial Intelligence | February 14, 2019
This Nuance-sponsored ITN webinar will be held at 1 p.m. Eastern time, Tuesday, Feb. 26, 2019.
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
MDW Partners With Bitfury and Longenesis to Deliver Next-Generation Healthcare Blockchain
News | Radiology Business | February 11, 2019
The Bitfury Group and Longenesis announced a partnership with Medical Diagnostics Web (MDW) to bring new...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...